| Madiha Haque, MD | |
|
Trios Care Center, 3730 Plaza , 4th Floor, Kennewick, WA 99338 | |
| (509) 221-6450 | |
| Not Available |
| Full Name | Madiha Haque |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 10 Years |
| Location | Trios Care Center, Kennewick, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467974170 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tri-cities Home Health | Kennewick, WA | Home health agency |
| Columbia River Home Health | Kennewick, WA | Home health agency |
| Trios Health | Kennewick, WA | Hospital |
| Kadlec Regional Medical Center | Richland, WA | Hospital |
| Lourdes Medical Center | Pasco, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rcch Trios Health Llc | 5799035416 | 56 |
News Archive
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today that its CellDetect non-invasive test for detecting bladder cancer in urine has obtained CE Marking, enabling the product to be marketed and sold in Europe and other territories.
The Michael J. Fox Foundation for Parkinson's Research announces the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and drug development against this promising disease-modification target.
A quantitative, molecular analysis of lymph nodes in patients deemed colorectal cancer-free was found to be an effective predictor of recurrence, according to a study from researchers at the Kimmel Cancer Center at Jefferson and published online Feb 9. in Clinical Cancer Research.
Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene - p53 - is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Center.
Martin Estacio was shelling out $800 per month for a health plan that didn't fit his two-state lifestyle. The retired San Bernardino firefighter lives between Oklahoma and California. But his health insurance policy, purchased in Oklahoma, didn't cover non-emergency care outside the state.
› Verified 3 days ago
| Entity Name | Rcch Trios Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831682806 PECOS PAC ID: 5799035416 Enrollment ID: O20180830000618 |
News Archive
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today that its CellDetect non-invasive test for detecting bladder cancer in urine has obtained CE Marking, enabling the product to be marketed and sold in Europe and other territories.
The Michael J. Fox Foundation for Parkinson's Research announces the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and drug development against this promising disease-modification target.
A quantitative, molecular analysis of lymph nodes in patients deemed colorectal cancer-free was found to be an effective predictor of recurrence, according to a study from researchers at the Kimmel Cancer Center at Jefferson and published online Feb 9. in Clinical Cancer Research.
Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene - p53 - is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Center.
Martin Estacio was shelling out $800 per month for a health plan that didn't fit his two-state lifestyle. The retired San Bernardino firefighter lives between Oklahoma and California. But his health insurance policy, purchased in Oklahoma, didn't cover non-emergency care outside the state.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Madiha Haque, MD Trios Care Center, 3730 Plaza , 4th Floor, Kennewick, WA 99338 Ph: (509) 221-6450 | Madiha Haque, MD Trios Care Center, 3730 Plaza , 4th Floor, Kennewick, WA 99338 Ph: (509) 221-6450 |
News Archive
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today that its CellDetect non-invasive test for detecting bladder cancer in urine has obtained CE Marking, enabling the product to be marketed and sold in Europe and other territories.
The Michael J. Fox Foundation for Parkinson's Research announces the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and drug development against this promising disease-modification target.
A quantitative, molecular analysis of lymph nodes in patients deemed colorectal cancer-free was found to be an effective predictor of recurrence, according to a study from researchers at the Kimmel Cancer Center at Jefferson and published online Feb 9. in Clinical Cancer Research.
Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene - p53 - is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Center.
Martin Estacio was shelling out $800 per month for a health plan that didn't fit his two-state lifestyle. The retired San Bernardino firefighter lives between Oklahoma and California. But his health insurance policy, purchased in Oklahoma, didn't cover non-emergency care outside the state.
› Verified 3 days ago
Rangaswamy Akhanda Chintapatla, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7350 W Deschutes Ave Ste B103, Kennewick, WA 99336 Phone: 509-783-0144 Fax: 509-783-8244 | |
Joel Ohrt, RESIDENT PHYSICIAN Internal Medicine Medicare: Medicare Enrolled Practice Location: 216 W 10th Ave Ste 204, Kennewick, WA 99336 Phone: 509-221-5677 | |
David Marcelino Sandoval, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6710 W Okanogan Place, Kennewick, WA 99336 Phone: 509-783-2000 Fax: 509-783-2008 | |
Dr. Elizabeth Clare Doolin, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 216 W 10th Ave Ste 202, Kennewick, WA 99336 Phone: 509-221-5510 | |
Carlos Ramirez Babinski, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3810 Plaza Way, Kennewick, WA 99338 Phone: 509-221-5510 | |
Ying Zhuo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7360 W Deschutes Ave, Kennewick, WA 99336 Phone: 509-783-0144 | |
Richard G Marquardt Ii, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 195706 E 30th Ave, Kennewick, WA 99337 Phone: 509-582-6057 |